HQL logo

HQL

Profile

Full Name

Abrdn Life Sciences Investors

Ticker Symbol

HQL

Exchange

NYSE

Country

United States

IPO

May 1, 1992

Indexes

Not included

Employees

-

Key Details

Price

$13.09(+0.54%)

Market cap

-

Last Dividend

$0.47

TTM Dividend yield

11.15%

Annual revenue

$86.69M(+268.50% YoY)

Annual EPS

-

PE ratio

-

Next earnings date

N/A

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name

Analyst ratings

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price Performance

Price Range

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Shares Outstanding

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Events

Dividend per share

Dividend yield

Other

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

EPS

Profit

Expenses

EBIT & EBITDA

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Liabilities

Debt

Equity & Capital

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

CAPEX

Free Cash Flow

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

ROA & ROE

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Analyst ratings

Recent major analysts updates

No data about analysts updates

Institutional Ownership

  • What is the ticker symbol for Tekla Life Sciences Investors?
  • Does Tekla Life Sciences Investors pay dividends?
  • What sector is Tekla Life Sciences Investors in?
  • What industry is Tekla Life Sciences Investors in?
  • What country is Tekla Life Sciences Investors based in?
  • When did Tekla Life Sciences Investors go public?
  • Is Tekla Life Sciences Investors in the S&P 500?
  • Is Tekla Life Sciences Investors in the NASDAQ 100?
  • Is Tekla Life Sciences Investors in the Dow Jones?
  • When does Tekla Life Sciences Investors report earnings?

What is the ticker symbol for Tekla Life Sciences Investors?

The ticker symbol for Tekla Life Sciences Investors is NYSE:HQL

Does Tekla Life Sciences Investors pay dividends?

Yes, Tekla Life Sciences Investors pays dividends. The last payment was $0.47, with an ex-dividend date on February 21, 2025

What sector is Tekla Life Sciences Investors in?

Tekla Life Sciences Investors is in the Financial Services sector

What industry is Tekla Life Sciences Investors in?

Tekla Life Sciences Investors is in the Asset Management industry

What country is Tekla Life Sciences Investors based in?

Tekla Life Sciences Investors is headquartered in United States

When did Tekla Life Sciences Investors go public?

Tekla Life Sciences Investors's initial public offering (IPO) was on May 1, 1992

Is Tekla Life Sciences Investors in the S&P 500?

No, Tekla Life Sciences Investors is not included in the S&P 500 index

Is Tekla Life Sciences Investors in the NASDAQ 100?

No, Tekla Life Sciences Investors is not included in the NASDAQ 100 index

Is Tekla Life Sciences Investors in the Dow Jones?

No, Tekla Life Sciences Investors is not included in the Dow Jones index

When does Tekla Life Sciences Investors report earnings?

The date for Tekla Life Sciences Investors's next earnings report has not been announced yet
On this page